Kembali ke Daftar Obat

Panduan penyiapan dan pemberian terapi medikasi
Digoxin (Injeksi)

Risiko Phlebitis rendah

Kejadian Jarang/Berpotensi (>1/1000 kejadian)
Tetap waspada, gunakan dengan prosedur standar

Penyiapan

Sediaan

  • 250 mcg/ml

Rekomendasi Pengenceran (Konsentrasi)

dapat diberikan tanpa diencerkan atau diencerkan 4x volume

Pelarut

  • D5%
  • NaCl 0.9%
  • WI

Pemberian

Rekomendasi Akses

IV
injeksi IM menyebabkan nekrosis otot dan nyeri

Rekomendasi Durasi Pemberian

10-20 menit. injeksi cepat menyebabkan vasokonstriksi sehingga terjadi hipertensi dan atau menurunkan aliran koroner

Stabilitas Obat Setelah Rekonstruksi

jika dilarutkan dalam rasio 1:250, stabil 48 jam suhu 20-25°C

Keamanan

pH

6.8-7.2
pH risiko rendah (5,0-7,5)

Osmolaritas Sebelum Pengenceran

9105 mOsm/kg
Osmolaritas tinggi (>900)
Harus melalui CVC

Phlebitis

Ya
Jarang/Berpotensi (>1/1000 kejadian)
Tetap waspada, gunakan dengan prosedur standar

Inkompatibilitas

  • Dobutamine HCl
  • Doxapram HCl
  • Pantoprazole sodium
  • Amiodarone HCl
  • Fluconazole
  • Foscarnet sodium
  • Insulin
  • Quinupristin–dalfopristin
  • Telavancin HCl

Klasifikasi GHS

Irritant
Acute Toxicity
Health Hazard
Environment Hazard

Manifestasi GHS

H300+H330 (31.1%): Fatal if swallowed or if inhaled [Danger Acute toxicity, oral; acute toxicity, inhalation]
H300 (86.1%): Fatal if swallowed [Danger Acute toxicity, oral]
H319 (50.8%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H330 (79.5%): Fatal if inhaled [Danger Acute toxicity, inhalation]

H331 (10.7%): Toxic if inhaled [Danger Acute toxicity, inhalation]
H372 (44.3%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]
H400 (54.9%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]

Sumber

  • https://www.medicines.org.uk/emc/product/5462/smpc#gref
  • American Society of Health-System Pharmacists. 2021. ASHP® Injectable Drug Information: A Comprehensive Guide to Compatibility and Stability. 2021 Edition. eBook. American Society of Health-System Pharmacists. ISBN: 978-1-58528-690-4. doi.org/10.37573/9781585286850